Iradimed (IRMD) EBT Margin Growth (3y) (2016 - 2026)
Iradimed (IRMD) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,391.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,114.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -176.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iradimed | 1.20 Bn | 1.14 Bn | 16.81 Mn | 724.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724.00 |
| Dec 31, 2025 | 269.00 |
| Sep 30, 2025 | 281.00 |
| Jun 30, 2025 | 305.00 |
| Mar 31, 2025 | 561.00 |
| Dec 31, 2024 | 650.00 |
| Sep 30, 2024 | 666.00 |
| Jun 30, 2024 | 1,603.00 |
| Mar 31, 2024 | 1,059.00 |
| Dec 31, 2023 | 2,478.00 |
| Sep 30, 2023 | 2,851.00 |
| Jun 30, 2023 | 7,569.00 |
| Mar 31, 2023 | 1,848.00 |
| Dec 31, 2022 | 1,003.00 |
| Sep 30, 2022 | 522.00 |
| Jun 30, 2022 | 626.00 |
| Mar 31, 2022 | 582.00 |
| Dec 31, 2021 | 373.00 |
| Sep 30, 2021 | 879.00 |
| Jun 30, 2021 | -416.00 |